Wells Fargo & Company Iovance Biotherapeutics, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 496,396 shares of IOVA stock, worth $4.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

496,396

Previous 367,787 34.97%

Holding current value

$4.97 Million

Previous $5.45 Million 26.95%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$7.78 - $14.19 $1 Million - $1.82 Million	128,609 Added 34.97%	496,396 $3.98 Million
Q1 2024 May 10, 2024	BUY	$7.59 - $17.47 $152,247 - $350,430	20,059 Added 5.77%	367,787 $5.45 Million
Q4 2023 Feb 09, 2024	SELL	$3.3 - $8.89 $611,955 - $1.65 Million	-185,441 Reduced 34.78%	347,728 $2.83 Million
Q3 2023 Nov 13, 2023	BUY	$4.44 - $8.79 $689,083 - $1.36 Million	155,199 Added 41.06%	533,169 $2.43 Million
Q2 2023 Aug 15, 2023	BUY	$5.36 - $9.06 $697,084 - $1.18 Million	130,053 Added 52.46%	377,970 $2.66 Million
Q1 2023 May 12, 2023	BUY	$5.53 - $8.22 $1.16 Million - $1.73 Million	210,126 Added 556.02%	247,917 $1.51 Million
Q4 2022 Feb 13, 2023	SELL	$5.62 - $10.0 $115,372 - $205,290	-20,529 Reduced 35.2%	37,791 $241,000
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $290,388 - $399,474	30,471 Added 109.42%	58,320 $558,000
Q2 2022 Aug 12, 2022	SELL	$6.38 - $18.33 $154,887 - $444,997	-24,277 Reduced 46.57%	27,849 $308,000
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $46,994 - $72,503	-3,796 Reduced 6.79%	52,126 $868,000
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $108,038 - $180,368	6,528 Added 13.22%	55,922 $1.07 Million
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $125,600 - $164,360	-6,172 Reduced 11.11%	49,394 $1.22 Million
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $84,720 - $171,567	-5,188 Reduced 8.54%	55,566 $1.45 Million
Q1 2021 May 13, 2021	SELL	$28.67 - $52.59 $329,303 - $604,048	-11,486 Reduced 15.9%	60,754 $1.92 Million
Q4 2020 Feb 09, 2021	SELL	$28.04 - $50.26 $1.25 Million - $2.24 Million	-44,567 Reduced 38.15%	72,240 $3.35 Million
Q3 2020 Nov 05, 2020	SELL	$27.75 - $36.3 $1.3 Million - $1.7 Million	-46,756 Reduced 28.59%	116,807 $3.85 Million
Q2 2020 Aug 13, 2020	BUY	$27.21 - $41.0 $1.52 Million - $2.29 Million	55,942 Added 51.98%	163,563 $4.49 Million
Q1 2020 May 14, 2020	BUY	$19.54 - $38.85 $2.1 Million - $4.18 Million	107,621 New	107,621 $3.22 Million

Others Institutions Holding IOVA

# of Institutions

323

Shares Held

239M

Call Options Held

1.27M

Put Options Held

1.68M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.58B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Iovance Biotherapeutics, Inc. Transaction History